Header Logo

Connection

Fernando Martinez to Anti-Inflammatory Agents

This is a "connection" page, showing publications Fernando Martinez has written about Anti-Inflammatory Agents.
Connection Strength

1.214
  1. Rennard SI, Calverley PM, Goehring UM, Bredenbr?ker D, Martinez FJ. Reduction of exacerbations by the PDE4 inhibitor roflumilast--the importance of defining different subsets of patients with COPD. Respir Res. 2011 Jan 27; 12:18.
    View in: PubMed
    Score: 0.316
  2. Berlin DA, Gulick RM, Martinez FJ. Severe Covid-19. N Engl J Med. 2020 Dec 17; 383(25):2451-2460.
    View in: PubMed
    Score: 0.151
  3. Han MK, Barreto TA, Martinez FJ, Comstock AT, Sajjan US. Randomised clinical trial to determine the safety of quercetin supplementation in patients with chronic obstructive pulmonary disease. BMJ Open Respir Res. 2020 02; 7(1).
    View in: PubMed
    Score: 0.148
  4. Hannah DM, Taboada CD, Tressler TB, Martinez FJ, Amicone LA, Wert Y. Analysis of clinical diagnosis for all patients receiving antenatal betamethasone in a community hospital. J Neonatal Perinatal Med. 2018; 11(3):295-303.
    View in: PubMed
    Score: 0.128
  5. Han MK, Tayob N, Murray S, Dransfield MT, Washko G, Scanlon PD, Criner GJ, Casaburi R, Connett J, Lazarus SC, Albert R, Woodruff P, Martinez FJ. Predictors of chronic obstructive pulmonary disease exacerbation reduction in response to daily azithromycin therapy. Am J Respir Crit Care Med. 2014 Jun 15; 189(12):1503-8.
    View in: PubMed
    Score: 0.100
  6. Martinez FJ, Donohue JF, Rennard SI. The future of chronic obstructive pulmonary disease treatment--difficulties of and barriers to drug development. Lancet. 2011 Sep 10; 378(9795):1027-37.
    View in: PubMed
    Score: 0.083
  7. Han MK, Martinez FJ. Pharmacotherapeutic approaches to preventing acute exacerbations of chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2011 Aug; 8(4):356-62.
    View in: PubMed
    Score: 0.082
  8. Han MK, Postma D, Mannino DM, Giardino ND, Buist S, Curtis JL, Martinez FJ. Gender and chronic obstructive pulmonary disease: why it matters. Am J Respir Crit Care Med. 2007 Dec 15; 176(12):1179-84.
    View in: PubMed
    Score: 0.062
  9. Martinez FJ, Standiford C, Gay SE. Is it asthma or COPD? The answer determines proper therapy for chronic airflow obstruction. Postgrad Med. 2005 Mar; 117(3):19-26.
    View in: PubMed
    Score: 0.052
  10. Newton CA, Zhang D, Oldham JM, Kozlitina J, Ma SF, Martinez FJ, Raghu G, Noth I, Garcia CK. Telomere Length and Use of Immunosuppressive Medications in Idiopathic Pulmonary Fibrosis. Am J Respir Crit Care Med. 2019 08 01; 200(3):336-347.
    View in: PubMed
    Score: 0.036
  11. Rabe KF, Calverley PMA, Martinez FJ, Fabbri LM. Effect of roflumilast in patients with severe COPD and a history of hospitalisation. Eur Respir J. 2017 07; 50(1).
    View in: PubMed
    Score: 0.031
  12. Scemla A, Gerber S, Duquesne A, Parize P, Martinez F, Anglicheau D, Snanoudj R, Zuber M, Bougnoux ME, Legendre C, Lortholary O. Dramatic improvement of severe cryptococcosis-induced immune reconstitution syndrome with adalimumab in a renal transplant recipient. Am J Transplant. 2015 Feb; 15(2):560-4.
    View in: PubMed
    Score: 0.026
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.